<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Breast Cancer Genomics | Cristea Lab</title>
    <link rel="stylesheet" href="../styles.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        .research-hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.9;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2.5rem;
            color: var(--primary-color);
            margin-bottom: 2rem;
            border-bottom: 3px solid var(--primary-color);
            padding-bottom: 0.5rem;
        }
        .project-card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--shadow);
            padding: 2.5rem;
            margin-bottom: 2rem;
            border-left: 5px solid var(--accent-color);
            transition: var(--transition);
        }
        .project-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.15);
        }
        .project-card h3 {
            font-size: 1.8rem;
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .project-card h4 {
            font-size: 1.3rem;
            color: var(--accent-color);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            font-size: 1.1rem;
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .project-details {
            background: var(--bg-light);
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        .project-details h5 {
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .methodology-list {
            list-style: none;
            padding: 0;
        }
        .methodology-list li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #eee;
        }
        .methodology-list li:last-child {
            border-bottom: none;
        }
        .methodology-list li::before {
            content: 'ðŸ”¬';
            margin-right: 0.5rem;
        }
        .impact-highlight {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid var(--secondary-color);
            margin: 2rem 0;
        }
        .impact-highlight h4 {
            color: var(--secondary-color);
            margin-bottom: 1rem;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--primary-color);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.9rem;
            font-weight: 500;
        }
        .prevention-highlight {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #4caf50;
            margin: 2rem 0;
        }
        .prevention-highlight h4 {
            color: #2e7d32;
            margin-bottom: 1rem;
        }
        .discovery-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .discovery-card {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            border-top: 4px solid var(--accent-color);
            text-align: center;
        }
        .clinical-translation {
            background: linear-gradient(135deg, #fff3e0, #ffe0b2);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #ff9800;
            margin: 2rem 0;
        }
        .clinical-translation h4 {
            color: #f57c00;
            margin-bottom: 1rem;
        }
        .immune-escape {
            background: linear-gradient(135deg, #ffebee, #ffcdd2);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #f44336;
            margin: 2rem 0;
        }
        .immune-escape h4 {
            color: #d32f2f;
            margin-bottom: 1rem;
        }
        .adc-highlight {
            background: linear-gradient(135deg, #e3f2fd, #bbdefb);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #2196f3;
            margin: 2rem 0;
        }
        .adc-highlight h4 {
            color: #1976d2;
            margin-bottom: 1rem;
        }
        .collaboration-network {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .collaborator-card {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            text-align: center;
            border-top: 3px solid var(--primary-color);
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">Computational Cancer Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../team.html" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>Breast Cancer Genomics</h1>
                <p>
                    Advancing breast cancer research through spatial and temporal single cell analyses of tumor initiation, 
                    malignant transformations, and clinical response prediction for innovative therapeutic strategies.
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    Our breast cancer research program focuses on understanding the earliest events in breast cancer 
                    development, from initial cellular transformations to immune evasion mechanisms. We employ cutting-edge 
                    single-cell genomics and spatial analysis techniques to map the evolution of breast cancer at 
                    unprecedented resolution, with the ultimate goal of developing prevention strategies and improving 
                    treatment outcomes.
                </div>
                
                <div class="impact-highlight">
                    <h4>Paradigm Shift: From Treatment to Prevention</h4>
                    <p>
                        Our research represents a fundamental shift from treating established breast cancers to understanding 
                        and preventing their formation. By studying the earliest cellular events in breast cancer development, 
                        we aim to identify intervention points that could prevent cancer before it becomes clinically apparent, 
                        potentially through mRNA vaccines and other preventive strategies.
                    </p>
                </div>
            </div>

            <!-- Research Area 1: Tumor Initiation -->
            <div class="research-section">
                <h2>Tumor Initiation & Stem Cell Transformations</h2>
                
                <!-- Project A: Novel Stem Cell Population -->
                <div class="project-card">
                    <h3>Project A: Novel Stem Cell Population for Breast Cancer Prevention</h3>
                    <div class="project-description">
                        We have discovered a novel stem cell population responsible for breast cancer prevention in rat models. 
                        This groundbreaking finding challenges conventional understanding of breast cancer initiation and 
                        opens new avenues for prevention-based therapies, including the potential development of mRNA vaccines.
                    </div>
                    
                    <div class="prevention-highlight">
                        <h4>Revolutionary Discovery</h4>
                        <p>
                            This research identifies specific cellular populations that actively prevent tumor formation, 
                            rather than simply lacking tumorigenic potential. Understanding these protective mechanisms 
                            could lead to the development of preventive therapies that enhance natural tumor suppression 
                            mechanisms in high-risk individuals.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Research Methodology</h5>
                        <ul class="methodology-list">
                            <li>Single-cell RNA sequencing of mammary stem cell populations</li>
                            <li>Lineage tracing of protective stem cell subsets</li>
                            <li>Functional validation through transplantation assays</li>
                            <li>Comparative analysis across cancer-resistant and susceptible models</li>
                            <li>Identification of prevention-associated molecular signatures</li>
                        </ul>
                    </div>

                    <div class="discovery-grid">
                        <div class="discovery-card">
                            <i class="fas fa-shield-alt" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Protective Mechanisms</h4>
                            <p>Active tumor suppression pathways</p>
                        </div>
                        <div class="discovery-card">
                            <i class="fas fa-syringe" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>mRNA Vaccine Targets</h4>
                            <p>Prevention-specific antigens</p>
                        </div>
                        <div class="discovery-card">
                            <i class="fas fa-microscope" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Biomarker Discovery</h4>
                            <p>Early detection signatures</p>
                        </div>
                    </div>

                    <div class="clinical-translation">
                        <h4>Clinical Translation Potential</h4>
                        <p>
                            This discovery has immediate implications for breast cancer prevention strategies. We are working 
                            to translate these findings into clinical applications, including the development of mRNA vaccines 
                            that could enhance protective stem cell function in high-risk women, such as those with BRCA 
                            mutations or strong family histories of breast cancer.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Stem Cell Biology</span>
                        <span class="tech-tag">Cancer Prevention</span>
                        <span class="tech-tag">mRNA Vaccines</span>
                        <span class="tech-tag">Lineage Tracing</span>
                        <span class="tech-tag">Single-cell Analysis</span>
                    </div>
                </div>

                <!-- Project B: Secretory Basal Cells -->
                <div class="project-card">
                    <h3>Project B: Secretory Basal Cells as Prevention-Associated Progenitors</h3>
                    <div class="project-description">
                        We have identified secretory basal cells as progenitors associated with breast tumor prevention. 
                        This research reveals how specific cellular differentiation programs can protect against malignant 
                        transformation and identifies new targets for prevention-based interventions.
                    </div>

                    <div class="project-details">
                        <h5>Secretory Basal Cell Characterization</h5>
                        <ul class="methodology-list">
                            <li>Single-cell transcriptomics of mammary epithelial populations</li>
                            <li>Spatial mapping of secretory basal cell distribution</li>
                            <li>Functional analysis of secreted factors and paracrine signaling</li>
                            <li>Developmental trajectory analysis from progenitors to differentiated cells</li>
                            <li>Comparison between normal and pre-malignant tissue environments</li>
                        </ul>
                    </div>

                    <div class="prevention-highlight">
                        <h4>Protective Secretome</h4>
                        <p>
                            Secretory basal cells produce a unique set of factors that create a protective microenvironment 
                            against tumor initiation. Understanding this secretome could lead to the development of preventive 
                            therapies that mimic or enhance these natural protective mechanisms.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Secretory Cells</span>
                        <span class="tech-tag">Paracrine Signaling</span>
                        <span class="tech-tag">Protective Secretome</span>
                        <span class="tech-tag">Tumor Prevention</span>
                        <span class="tech-tag">Mammary Development</span>
                    </div>
                </div>
            </div>

            <!-- Research Area 2: Immune Analyses -->
            <div class="research-section">
                <h2>Spatial & Temporal Immune Analyses</h2>
                
                <!-- Project A: TCR Clonotype Diversity -->
                <div class="project-card">
                    <h3>Project A: Peripheral Blood TCR Clonotype Diversity</h3>
                    <div class="project-description">
                        We investigate peripheral blood T-cell receptor (TCR) clonotype diversity as an age-associated 
                        marker of breast cancer progression. This work reveals how immune repertoire changes can serve 
                        as early biomarkers for cancer development and progression.
                    </div>

                    <div class="project-details">
                        <h5>TCR Repertoire Analysis</h5>
                        <ul class="methodology-list">
                            <li>High-throughput TCR sequencing from peripheral blood samples</li>
                            <li>Longitudinal tracking of clonotype dynamics</li>
                            <li>Age-stratified analysis of immune repertoire diversity</li>
                            <li>Correlation with cancer progression and clinical outcomes</li>
                            <li>Integration with tumor-infiltrating lymphocyte analysis</li>
                        </ul>
                    </div>

                    <div class="impact-highlight">
                        <h4>Published Impact: PNAS 2023</h4>
                        <p>
                            This work was published as a co-first and co-senior author paper in PNAS (Jun Nishida*, 
                            <strong>Simona Cristea</strong>*+, et al., 2023). The study demonstrates that TCR diversity 
                            patterns in blood can predict breast cancer progression, providing a non-invasive biomarker 
                            for disease monitoring and potentially early detection.
                        </p>
                    </div>

                    <div class="clinical-translation">
                        <h4>Liquid Biopsy Applications</h4>
                        <p>
                            This research enables the development of blood-based tests for breast cancer monitoring and 
                            early detection. TCR repertoire analysis could be incorporated into routine screening programs, 
                            particularly for high-risk populations, providing a minimally invasive method for cancer 
                            surveillance.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">TCR Sequencing</span>
                        <span class="tech-tag">Immune Repertoire</span>
                        <span class="tech-tag">Liquid Biopsy</span>
                        <span class="tech-tag">Age-Associated Markers</span>
                        <span class="tech-tag">PNAS 2023</span>
                    </div>
                </div>

                <!-- Project B: Cycling T Regulatory Cells -->
                <div class="project-card">
                    <h3>Project B: Cycling T Regulatory Cells in Immune Escape</h3>
                    <div class="project-description">
                        We have identified a subpopulation of cycling T regulatory cells that creates an immune escape hub 
                        during the transition from in situ to invasive breast carcinoma. This discovery reveals a critical 
                        window for immune intervention and provides new targets for immunotherapy.
                    </div>

                    <div class="immune-escape">
                        <h4>Critical Transition Point</h4>
                        <p>
                            The transition from ductal carcinoma in situ (DCIS) to invasive breast cancer represents a 
                            critical juncture where early intervention could prevent cancer progression. Our identification 
                            of cycling T regulatory cells as key mediators of this transition provides specific targets 
                            for preventing cancer invasion.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Immune Escape Mechanism Analysis</h5>
                        <ul class="methodology-list">
                            <li>Single-cell analysis of immune populations in DCIS vs. invasive cancer</li>
                            <li>Spatial mapping of T regulatory cell distribution</li>
                            <li>Cell cycle analysis of regulatory T cell populations</li>
                            <li>Functional validation of immune suppression mechanisms</li>
                            <li>Identification of therapeutic targets for immune restoration</li>
                        </ul>
                    </div>

                    <div class="impact-highlight">
                        <h4>Under Review: Nature Immunology</h4>
                        <p>
                            This groundbreaking work is currently under revision at Nature Immunology as a senior author 
                            publication. The findings provide new insights into immune evasion mechanisms and identify 
                            specific time points and cellular targets for immune-based interventions to prevent cancer 
                            progression.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Therapeutic Implications</h5>
                        <p>
                            Understanding how cycling T regulatory cells facilitate immune escape opens new avenues for 
                            early intervention. Targeting these cells during the DCIS stage could prevent progression to 
                            invasive cancer, fundamentally changing breast cancer treatment from reactive to preventive.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Regulatory T cells</span>
                        <span class="tech-tag">Immune Escape</span>
                        <span class="tech-tag">DCIS Transition</span>
                        <span class="tech-tag">Spatial Immunology</span>
                        <span class="tech-tag">Nature Immunology</span>
                    </div>
                </div>
            </div>

            <!-- Research Area 3: Clinical Response Prediction -->
            <div class="research-section">
                <h2>Triple-Negative Breast Cancer Clinical Applications</h2>
                
                <!-- Project A: Biopsy Collection Framework -->
                <div class="project-card">
                    <h3>Project A: Single Cell Analysis Framework for Clinical Trials</h3>
                    <div class="project-description">
                        We have developed comprehensive frameworks for biopsy collection and single-cell analysis in clinical 
                        trial settings for breast cancer patients. This infrastructure enables real-time analysis of treatment 
                        responses and biomarker discovery in clinical contexts.
                    </div>

                    <div class="project-details">
                        <h5>Clinical Trial Integration</h5>
                        <ul class="methodology-list">
                            <li>Standardized biopsy collection protocols for single-cell analysis</li>
                            <li>Real-time processing of clinical samples</li>
                            <li>Integration with clinical trial databases and outcomes</li>
                            <li>Quality control measures for clinical-grade genomics data</li>
                            <li>Regulatory compliance for translational research</li>
                        </ul>
                    </div>

                    <div class="clinical-translation">
                        <h4>Published Framework: npj Precision Oncology 2021</h4>
                        <p>
                            Our systematic approach to tissue collection during clinical breast biopsy was published in 
                            npj Precision Oncology (Siang-Boon Koh, Brian N Dontchos, et al., including <strong>Simona Cristea</strong>, 2021). 
                            This work demonstrates that comprehensive translational analyses are feasible and safe in 
                            routine clinical practice.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Clinical Trials</span>
                        <span class="tech-tag">Biopsy Protocols</span>
                        <span class="tech-tag">Single-cell Genomics</span>
                        <span class="tech-tag">Translational Research</span>
                        <span class="tech-tag">npj Precision Oncology</span>
                    </div>
                </div>

                <!-- Project B: ADC Response Prediction -->
                <div class="project-card">
                    <h3>Project B: Spatio-temporal Profiling of Antibody-Drug Conjugate Response</h3>
                    <div class="project-description">
                        We conduct comprehensive spatio-temporal profiling of antibody-drug conjugate (ADC) response in 
                        triple-negative breast cancer clinical trial data, focusing on Sacituzumab Govitecan treatment. 
                        This work aims to predict treatment responses and optimize ADC therapy strategies.
                    </div>

                    <div class="adc-highlight">
                        <h4>Sacituzumab Govitecan Analysis</h4>
                        <p>
                            Sacituzumab Govitecan represents a breakthrough in triple-negative breast cancer treatment, 
                            but not all patients respond to this therapy. Our spatial and temporal analysis of tumor 
                            samples from treated patients aims to identify predictive biomarkers and understand resistance 
                            mechanisms to optimize patient selection and treatment strategies.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Multi-dimensional Analysis</h5>
                        <ul class="methodology-list">
                            <li>Pre-treatment and post-treatment single-cell profiling</li>
                            <li>Spatial analysis of ADC distribution and response</li>
                            <li>Temporal tracking of cellular responses to treatment</li>
                            <li>Integration of genomic, transcriptomic, and proteomic data</li>
                            <li>Predictive modeling for treatment response</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Clinical Impact</h5>
                        <p>
                            This research directly impacts patient care by identifying biomarkers that can predict 
                            response to Sacituzumab Govitecan before treatment initiation. These predictive models 
                            enable personalized treatment selection and help identify patients who would benefit 
                            from alternative therapies.
                        </p>
                    </div>

                    <div class="impact-highlight">
                        <h4>Manuscript in Preparation</h4>
                        <p>
                            High-resolution profiling of antibody-drug conjugate response in triple-negative breast cancer 
                            (Liu et al., manuscript in preparation, to be submitted in 2025). This work represents one of 
                            the most comprehensive analyses of ADC response mechanisms in clinical samples.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Antibody-Drug Conjugates</span>
                        <span class="tech-tag">Sacituzumab Govitecan</span>
                        <span class="tech-tag">Triple-Negative Breast Cancer</span>
                        <span class="tech-tag">Response Prediction</span>
                        <span class="tech-tag">Spatial Analysis</span>
                    </div>
                </div>
            </div>

            <!-- Key Collaborations -->
            <div class="research-section">
                <h2>Key Collaborations</h2>
                <div class="project-card">
                    <h3>Interdisciplinary Research Network</h3>
                    <div class="project-description">
                        Our breast cancer research is conducted in close collaboration with leading clinicians and 
                        researchers across multiple institutions. These partnerships ensure that our discoveries are 
                        clinically relevant and can be rapidly translated to patient benefit.
                    </div>

                    <div class="collaboration-network">
                        <div class="collaborator-card">
                            <h4>Dr. Kornelia Polyak</h4>
                            <p>Dana-Farber Cancer Institute<br>Breast Cancer Research</p>
                        </div>
                        <div class="collaborator-card">
                            <h4>Dr. Leif Ellisen</h4>
                            <p>Massachusetts General Hospital<br>Breast Oncology</p>
                        </div>
                        <div class="collaborator-card">
                            <h4>Dr. Franziska Michor</h4>
                            <p>Dana-Farber Cancer Institute<br>Computational Biology</p>
                        </div>
                        <div class="collaborator-card">
                            <h4>Clinical Trial Teams</h4>
                            <p>Multi-institutional<br>Clinical Translation</p>
                        </div>
                    </div>

                    <div class="project-details">
                        <h5>Collaborative Research Outcomes</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Prevention Research</strong> - Novel stem cell populations and mRNA vaccine development</li>
                            <li><strong>Immune Evasion Studies</strong> - Cycling T regulatory cells and intervention strategies</li>
                            <li><strong>Clinical Translation</strong> - ADC response prediction and biomarker validation</li>
                            <li><strong>Methodology Development</strong> - Clinical trial integration frameworks</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Future Directions -->
            <div class="research-section">
                <h2>Future Directions</h2>
                <div class="impact-highlight">
                    <h4>Integration with Pancreatic Cancer Research</h4>
                    <p>
                        While our current breast cancer research continues with our established collaborators, we are 
                        exploring opportunities to apply our methodological innovations to pancreatic cancer. The single-cell 
                        analysis frameworks, spatial profiling techniques, and immune modeling approaches developed for 
                        breast cancer research will inform our pancreatic cancer early detection and treatment strategies.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>Computational Cancer Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script.js"></script>
</body>
</html>